ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAYMOND JAMES & ASSOCIATES | 10,449 | $9,665 | 0.00% |
| Cubist Systematic Strategies, LLC | 10,049 | $9,295 | 0.00% |
| UBS Group AG | 30,980 | $28,657 | 0.00% |
| RHUMBLINE ADVISERS | 5,582 | $5,163 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,714 | $1,585 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 110,174 | $101,911 | 0.00% |
| Douglas Lane & Associates, LLC | 13,000 | $12,025 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,258 | $2,088 | 0.00% |
| FMR LLC | 1,733,590 | $1,603,570 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 88,580 | $81,970 | 0.00% |
| US BANCORP \DE\ | 1,058 | $979 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,698,419 | $4,346,038 | 0.00% |
| STIFEL FINANCIAL CORP | 29,833 | $27,598 | 0.00% |
| WELLS FARGO & COMPANY/MN | 60,237 | $55,719 | 0.00% |
| NORTHERN TRUST CORP | 58,769 | $54,361 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 4,168 | $3 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,541 | $15,300 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 117,909 | $109,065 | 0.00% |
| STATE STREET CORP | 290,974 | $269,151 | 0.00% |
External links
This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q2 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.